82
Views
2
CrossRef citations to date
0
Altmetric
Commentary

BH3-mimetics – the solution to chemoresistance?

, &
Pages 1069-1072 | Received 02 May 2009, Accepted 03 May 2009, Published online: 21 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jamal Joudeh & David Claxton. (2012) Obatoclax mesylate: pharmacology and potential for therapy of hematological neoplasms. Expert Opinion on Investigational Drugs 21:3, pages 363-373.
Read now

Articles from other publishers (1)

Ahmet Cingöz, Ezgi Ozyerli-Goknar, Tunc Morova, Fidan Seker-Polat, Myvizhi Esai Selvan, Zeynep Hülya Gümüş, Deepak Bhere, Khalid Shah, Ihsan Solaroglu & Tugba Bagci-Onder. (2021) Generation of TRAIL-resistant cell line models reveals distinct adaptive mechanisms for acquired resistance and re-sensitization. Oncogene 40:18, pages 3201-3216.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.